Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Beauty Health (SKIN) Shares Outstanding (Weighted Average) (2020 - 2025)

Beauty Health (SKIN) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $126.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.58% to $126.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $126.0 million, a 1.58% increase, with the full-year FY2024 number at $123.8 million, down 5.96% from a year prior.
  • Shares Outstanding (Weighted Average) was $126.0 million for Q3 2025 at Beauty Health, roughly flat from $126.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $150.7 million in Q2 2022 to a low of $11.5 million in Q1 2021.
  • A 5-year average of $121.6 million and a median of $126.1 million in 2025 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 1223.06% in 2021, then decreased 12.07% in 2023.
  • Beauty Health's Shares Outstanding (Weighted Average) stood at $102.1 million in 2021, then surged by 44.5% to $147.6 million in 2022, then dropped by 10.76% to $131.7 million in 2023, then fell by 5.96% to $123.8 million in 2024, then rose by 1.77% to $126.0 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Shares Outstanding (Weighted Average) are $126.0 million (Q3 2025), $126.1 million (Q2 2025), and $125.1 million (Q1 2025).